- Home
- RGTI vs ALKS Comparison
RGTI vs ALKS Comparison
Compare RGTI & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGTI | ALKS |
|---|---|---|
| Founded | 2013 | 1987 |
| Country | United States | Ireland |
| Employees | 164 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 7.0B |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | RGTI | ALKS |
|---|---|---|
| Price | $20.53 | $42.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | $30.78 | ★ $43.43 |
| AVG Volume (30 Days) | ★ 51.1M | 2.0M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,475,899,000.00 |
| Revenue This Year | $225.06 | $24.26 |
| Revenue Next Year | $99.56 | $4.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.01 | $25.17 |
| 52 Week High | $58.15 | $44.57 |
Technical Indicators
Market Signals| Indicator | RGTI | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 46.94 | 69.90 |
| Support Level | $14.51 | $27.65 |
| Resistance Level | $27.16 | N/A |
| Average True Range (ATR) | 2.64 | 1.47 |
| MACD | -0.15 | 0.39 |
| Stochastic Oscillator | 37.66 | 76.44 |
Price Performance
Historical ComparisonAbout RGTI Rigetti Computing Inc.
Rigetti Computing Inc builds quantum computers and the superconducting quantum processors that power them. The Company sells 9-qubit to 108-qubit quantum computing systems under the Novera and Cepheus trade names. Through the Rigetti Quantum Cloud Services (QCS) platform, the Company's machines can be integrated into any public, private or hybrid cloud. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Mumbai, India. The Company's revenue is derived from operations in the United States and the United Kingdom.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.